Informations:
Erreur:
ID
28379
Description
Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency; ODM derived from: https://clinicaltrials.gov/show/NCT00709865
Lien
https://clinicaltrials.gov/show/NCT00709865
Mots-clés
Versions (1)
- 09/01/2018 09/01/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
9 janvier 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Congestive Heart Failure NCT00709865
Eligibility Congestive Heart Failure NCT00709865
- StudyEvent: Eligibility
Similar models
Eligibility Congestive Heart Failure NCT00709865
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Heart failure
Item
previous diagnosis of heart failure.
boolean
C0018801 (UMLS CUI [1])
ADHF | Hospitalization Required | Volume overload
Item
must have adhf, requiring hospitalization, with clinical evidence for volume overload
boolean
C1609524 (UMLS CUI [1])
C1708385 (UMLS CUI [2])
C0546817 (UMLS CUI [3])
C1708385 (UMLS CUI [2])
C0546817 (UMLS CUI [3])
Xanthine allergy
Item
history of an allergic reaction to any xanthine-containing substance.
boolean
C0571073 (UMLS CUI [1])
Epilepsy
Item
history of seizure
boolean
C0014544 (UMLS CUI [1])
Cerebrovascular accident
Item
history of stroke
boolean
C0038454 (UMLS CUI [1])
Myocardial Infarction
Item
myocardial infarction
boolean
C0027051 (UMLS CUI [1])
Primary valvular heart disease Hemodynamic Significant uncorrected | Obstructive Cardiomyopathy | Restrictive cardiomyopathy
Item
uncorrected hemodynamically significant primary valvular disease or known obstructive or restrictive cardiomyopathy.
boolean
C2064629 (UMLS CUI [1,1])
C0019010 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,3])
C4072785 (UMLS CUI [1,4])
C0007194 (UMLS CUI [2])
C0007196 (UMLS CUI [3])
C0019010 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,3])
C4072785 (UMLS CUI [1,4])
C0007194 (UMLS CUI [2])
C0007196 (UMLS CUI [3])
Sepsis Serious
Item
serious systemic infection
boolean
C0243026 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,2])
Major surgery
Item
major surgical procedures within 30 days
boolean
C0679637 (UMLS CUI [1])
Acute Coronary Syndrome
Item
acute coronary syndrome
boolean
C0948089 (UMLS CUI [1])
Shock, Cardiogenic
Item
cardiogenic shock
boolean
C0036980 (UMLS CUI [1])
Body Weight
Item
baseline body weight >150 kg
boolean
C0005910 (UMLS CUI [1])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device
Item
participation in any other investigational study of drugs or devices within 30 days prior to screening
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
Breast Feeding | Pregnancy | Pregnancy, Planned
Item
nursing mothers, pregnant women, or women planning on becoming pregnant during the study
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0032961 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Medical condition Interferes with Study Subject Participation Status
Item
presence of any clinically significant condition that might interfere with optimal safe participation in this study
boolean
C3843040 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])